A cardiac organoid approach combined with phosphoproteomics and single nuclei RNA-sequencing identifies bromodomain and extraterminal family inhibitors as promising candidates to prevent COVID-19 mediated cardiac damage.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025058 | PMC |
http://dx.doi.org/10.1038/s41569-021-00550-3 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!